131 related articles for article (PubMed ID: 36505021)
1. [Prostatic Lymphoma: a rare cause of urinary retention (a case report)].
Namaoui RY; Benremouga MC; Boutoura S; Rahali MC; Hadjaoui W; Zerabib A; Belbekri L; Zar F; Berrah H; Mouats A; Bessaïh A
Pan Afr Med J; 2022; 43():33. PubMed ID: 36505021
[TBL] [Abstract][Full Text] [Related]
2. Burkitt's lymphoma of the prostate presenting as acute urinary retention: a case report.
Derigs M; Pehl A; Riera-Knorrenschild J; Hofmann R; Hegele A
BMC Urol; 2020 May; 20(1):53. PubMed ID: 32375712
[TBL] [Abstract][Full Text] [Related]
3. A case report of primary prostate intravascular large B cell lymphoma presenting as prostatic hyperplasia.
Zhu F; Pan H; Xiao Y; Li Q; Liu T; Liu X; Wu G; Li J; Zhang L
Medicine (Baltimore); 2019 Dec; 98(50):e18384. PubMed ID: 31852153
[TBL] [Abstract][Full Text] [Related]
4. An unusual pathological finding of chronic lymphocitic leukemia and adenocarcinoma of the prostate after transurethral resection for complete urinary retention: case report.
Ballario R; Beltrami P; Cavalleri S; Ruggera L; Zorzi MG; Artibani W
BMC Cancer; 2004 Dec; 4():95. PubMed ID: 15615590
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen and transition zone index - powerful predictors for acute urinary retention in men with benign prostatic hyperplasia.
Milonas D; Trumbeckas D
Medicina (Kaunas); 2003; 39(11):1071-7. PubMed ID: 14646460
[TBL] [Abstract][Full Text] [Related]
6. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
van Vuuren SP; Heyns CF; Zarrabi AD
BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
[TBL] [Abstract][Full Text] [Related]
7. Prostatic Lymphoma Masquerading as Urinary Retention and Hematuria With Review of Literature.
Tamang TGL; Singh P; Garellek J; Malhotra S; Chandra AB; Solomon W
World J Oncol; 2017 Aug; 8(4):132-135. PubMed ID: 29147449
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of PSA in the detection of carcinoma of the prostate in patients presenting with acute urinary retention.
McNeill SA; Hargreave TB
J R Coll Surg Edinb; 2000 Aug; 45(4):227-30. PubMed ID: 11130021
[TBL] [Abstract][Full Text] [Related]
9. B-lymphocytic infiltration of the prostate to a patient with chronic lymphocytic leukemia. A case report.
Anastasiou I; Skoufias S; Katafigiotis I; Skarmoutsos I; Constantinides CA
Arch Ital Urol Androl; 2017 Mar; 89(1):83-84. PubMed ID: 28403603
[TBL] [Abstract][Full Text] [Related]
10. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.
Kwiatkowski MK; Recker F; Piironen T; Pettersson K; Otto T; Wernli M; Tscholl R
Urology; 1998 Sep; 52(3):360-5. PubMed ID: 9730444
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
[TBL] [Abstract][Full Text] [Related]
12. Primary manifestation of small Lymphocytic Lymphoma in the Prostate: A case report.
Kassar O; Gouiaa N; Mdhaffar M; Bellaaj H; Mseddi S; Boudawara T; Mhiri N; Elloumi M
Tunis Med; 2015 Apr; 93(4):249-58. PubMed ID: 26375744
[TBL] [Abstract][Full Text] [Related]
13. Treatment-refractory non-Hodgkin lymphoma of the prostate: A case report and review of the literature.
Galante A; Asirvatham RJ; Yeung LL
Urol Case Rep; 2019 May; 24():100867. PubMed ID: 31211077
[TBL] [Abstract][Full Text] [Related]
14. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. Free-to-total prostate-specific antigen (PSA) ratio improves the specificity for detecting prostate cancer in patients with prostatism and intermediate PSA levels.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Goepel M; Tscholl R
Br J Urol; 1998 Apr; 81(4):532-8. PubMed ID: 9598623
[TBL] [Abstract][Full Text] [Related]
17. Serum-to-urinary prostate-specific antigen ratio: a potential means of distinguishing benign prostatic hyperplasia from prostate cancer.
Irani J; Millet C; Levillain P; Doré B; Begon F; Aubert J
Eur Urol; 1996; 29(4):407-12. PubMed ID: 8791046
[TBL] [Abstract][Full Text] [Related]
18. [Primary Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma with Large Cell Transformation of the Prostate : A Case Report].
Kinjo T; Yamanaka Y; Katayama K; Minato N; Mori N; Yoshioka T; Onishi M; Sugahara H; Fujita S
Hinyokika Kiyo; 2015 Jul; 61(7):293-8. PubMed ID: 26278216
[TBL] [Abstract][Full Text] [Related]
19. Relation between acute urinary retention, chronic prostatic inflammation and accompanying elevated prostate-specific antigen.
Kefi A; Koseoglu H; Celebi I; Yorukoglu K; Esen A
Scand J Urol Nephrol; 2006; 40(2):155-60. PubMed ID: 16608815
[TBL] [Abstract][Full Text] [Related]
20. Lymphoma of the prostate presenting as benign prostatic hypertrophy.
Doll DC; Weiss RB; Shah S
South Med J; 1978 Sep; 71(9):1170-1. PubMed ID: 80035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
